Sputnik V to Begin Production in India from Aug, 3 Mn Doses Will be Supplied by May-end

·1-min read

Russian Covid-19 vaccine Sputnik V will begin production in India from August, said country’s envoy to Russia, DB Venkatesh Varma, on Saturday. He added that by end of May, above three million doses will be supplied in bulk and in June the number is expected to increase to five million.

Sputnik V has been approved to be imported from Russia by Dr Reddy’s, but is yet to be widely available in the country. The company had said the imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, amounting to Rs 995.4 per dose. Only three vaccines have been approved to be sold in India — Covaxin, Coveshield and Sputnik V.

The first consignment of imported doses of the vaccine from Russian Direct Investment Fund (RDIF) landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory.

Reddy’s Laboratories had earlier in the month soft-launched imported Covid-19 vaccine, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot.

Read all the Latest News, Breaking News and Coronavirus News here

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting